{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:51Z","timestamp":1786118631999,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/qco.0b013e32805dfb2d","type":"journal-article","created":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T03:55:13Z","timestamp":1172634913000},"page":"118-123","source":"Crossref","is-referenced-by-count":59,"title":["Acute bacterial skin infections and cellulitis"],"prefix":"10.1097","volume":"20","author":[{"given":"Marion","family":"Gabillot-Carr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210211","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9343(97)00160-5","article-title":"Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognosis indicators and microbiologic analysis of seventy-seven cases","volume":"103","author":"Kaul","year":"1997","journal-title":"Am J Med"},{"key":"R2-3-20210211","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1468-3083.2006.01657.x","article-title":"Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands","volume":"20","author":"Goettsch","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R3-3-20210211","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.318.7198.1591","article-title":"Risk factors for erysipelas of the leg (cellulitis): case-control study","volume":"318","author":"Dupuy","year":"1999","journal-title":"BMJ"},{"key":"R4-3-20210211","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000080853","article-title":"Chronic derematomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study","volume":"309","author":"Roujeau","year":"2004","journal-title":"Dermatology"},{"key":"R5-3-20210211","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/497127","article-title":"Risk factors for acute cellulitis of the lower limb: a prospective case-control study","volume":"41","author":"Bjornsdottir","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R6-3-20210211","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000090649","article-title":"Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study","volume":"212","author":"Mokni","year":"2006","journal-title":"Dermatology"},{"key":"R7-3-20210211","first-page":"430","article-title":"Microbiology and factors affecting mortality in necrotizing fasciitis","volume":"38","author":"Liu","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"key":"R8-3-20210211","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.md.0000085060.63483.bb","article-title":"Assessing the relationship between the use of nonsteroidal anti-inflammatory drugs and necrotizing fasciitis caused by group A streptococcus","volume":"82","author":"Aronoff","year":"2003","journal-title":"Medicine"},{"key":"R9-3-20210211","first-page":"177","article-title":"Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy","volume":"75","author":"Dall","year":"2005","journal-title":"Cutis"},{"key":"R10-3-20210211","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the management of skin and soft tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R11-3-20210211","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1001\/archinte.1988.00380110091019","article-title":"Influence of underlying disease process on the utility of cellulitis needle aspirates","volume":"148","author":"Kielhofner","year":"1988","journal-title":"Arch Intern Med"},{"key":"R12-3-20210211","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archderm.1989.01670180051004","article-title":"Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique","volume":"125","author":"Bernard","year":"1989","journal-title":"Arch Dermatol"},{"key":"R13-3-20210211","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3201\/eid1005.030604","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus among military recruits","volume":"10","author":"Zinderman","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"R14-3-20210211","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3201\/eid1106.040641","article-title":"Methicillin-resistant Staphylococcus aureus in community-acquired skin infections","volume":"11","author":"Moran","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R15-3-20210211","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N Engl J Med"},{"key":"R16-3-20210211","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3201\/eid1104.041094","article-title":"Recurring methicillin-resistant Staphylococcus aureus infections in a football team","volume":"11","author":"Nguyen","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R17-3-20210211","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1086\/425313","article-title":"A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns","volume":"39","author":"Begier","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R18-3-20210211","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"JAMA"},{"key":"R19-3-20210211","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00001432-200208000-00009","article-title":"New trends in Staphylococcus aureus infections: glycopetide resistance in hospital and methicillin resistance in the community","volume":"15","author":"Hiramatsu","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"R20-3-20210211","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa042859","article-title":"A clone of methicillin-resistant Staphylococcus aureus among professional football players","volume":"352","author":"Kazakova","year":"2005","journal-title":"N Engl J Med"},{"key":"R21-3-20210211","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/JCM.41.11.5113-5120.2003","article-title":"Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database","volume":"41","author":"McDougal","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R22-3-20210211","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000151107.29132.70","article-title":"Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas","volume":"24","author":"Mishaan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R23-3-20210211","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N Engl J Med"},{"key":"R24-3-20210211","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10096-004-1125-5","article-title":"Four cases of necrotizing fasciitis caused by Klebsiella species","volume":"23","author":"Wong","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R25-3-20210211","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5694\/j.1326-5377.1995.tb139878.x","article-title":"Home intravenous therapy. A safe and effective alternative to inpatient care","volume":"162","author":"Grayson","year":"1995","journal-title":"Med J Aust"},{"key":"R26-3-20210211","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bmj.38309.447975.EB","article-title":"Randomized controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital","volume":"330","author":"Corwin","year":"2005","journal-title":"BMJ"},{"key":"R27-3-20210211","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/emj.2004.018143","article-title":"Emergency department management of home intravenous antibiotic therapy for cellulitis","volume":"22","author":"Donald","year":"2005","journal-title":"Emerg Med J"},{"key":"R28-3-20210211","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1086\/340056","article-title":"Once daily IV cephazolin plus oral probenecid is equivalent to once daily IV ceftriaxone plus oral placebo for the treatment of moderate to severe cellulitis","volume":"34","author":"Grayson","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R29-3-20210211","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1345\/aph.1D251","article-title":"Once-daily cefazolin and probenecid for skin and soft tissue infections","volume":"38","author":"Cox","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R30-3-20210211","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa043252","article-title":"Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities","volume":"352","author":"Fridkin","year":"2005","journal-title":"N Engl J Med"},{"key":"R31-3-20210211","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.inf.0000109288.06912.21","article-title":"Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus","volume":"23","author":"Lee","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R32-3-20210211","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/383472","article-title":"Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens","volume":"38","author":"Carpenter","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R33-3-20210211","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijantimicag.2004.11.006","article-title":"Tigecycline: clinical evidence and formulary positioning","volume":"25","author":"Nathwani","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"R34-3-20210211","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R35-3-20210211","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Matthew","year":"2004","journal-title":"Arch Intern Med"},{"key":"R36-3-20210211","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1468-3083.2006.01648.x","article-title":"Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study","volume":"20","author":"Vignes","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R37-3-20210211","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darrenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R38-3-20210211","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/376652","article-title":"Dilemmas in the treatment of invasive Streptococcus pyogenes infections","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R39-3-20210211","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(94)90629-7","article-title":"Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features","volume":"344","author":"Chelsom","year":"1994","journal-title":"Lancet"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QCO.0b013e32805dfb2d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:19:48Z","timestamp":1786033188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001432-200704000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0b013e32805dfb2d","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}